SHELDON KAPLAN to Linezolid
This is a "connection" page, showing publications SHELDON KAPLAN has written about Linezolid.
Connection Strength
0.355
-
Use of linezolid in children. Introduction. Pediatr Infect Dis J. 2003 Sep; 22(9 Suppl):S151-2.
Score: 0.055
-
Linezolid for the treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr Infect Dis J. 2003 Sep; 22(9 Suppl):S178-85.
Score: 0.055
-
Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children. Pediatr Infect Dis J. 2003 Aug; 22(8):677-86.
Score: 0.054
-
Use of linezolid in children. Pediatr Infect Dis J. 2002 Sep; 21(9):870-2.
Score: 0.051
-
Linezolid for the treatment of community-acquired pneumonia in hospitalized children. Linezolid Pediatric Pneumonia Study Group. Pediatr Infect Dis J. 2001 May; 20(5):488-94.
Score: 0.046
-
In vitro activities of oxazolidinones U-100592 and U-100766 against penicillin-resistant and cephalosporin-resistant strains of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1996 Apr; 40(4):1039-40.
Score: 0.033
-
The use of linezolid in the treatment of paediatric patients with infections caused by enterococci including strains resistant to vancomycin. J Antimicrob Chemother. 2010 Oct; 65(10):2267-70.
Score: 0.022
-
Linezolid for the treatment of complicated skin and skin structure infections in children. Pediatr Infect Dis J. 2003 Sep; 22(9 Suppl):S172-7.
Score: 0.014
-
Hematologic effects of linezolid in young children. Pediatr Infect Dis J. 2003 Sep; 22(9 Suppl):S186-92.
Score: 0.014
-
Hematologic effects of linezolid: summary of clinical experience. Antimicrob Agents Chemother. 2002 Aug; 46(8):2723-6.
Score: 0.013